News | October 12, 2021
Skanray to raise Rs 400 crore to fund its inorganic growth
Since its inception, the company has either acquired or taken a majority stake in five companies
Since its inception, the company has either acquired or taken a majority stake in five companies
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Domestic business was up 41.9% YoY and 27.7% QoQ
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Subscribe To Our Newsletter & Stay Updated
